|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1993-2-2
|
|
pubmed:abstractText |
To estimate the disease-free survival rate in children with grossly resected hepatoblastoma treated with cisplatin, vincristine, and fluorouracil (CDDP/VCR/FU) and to assess the disease-response rate and disease-free survival (DFS) rate in children with unresectable or metastatic tumors treated with this combination.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
96-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8380296-Actuarial Analysis,
pubmed-meshheading:8380296-Adolescent,
pubmed-meshheading:8380296-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8380296-Carcinoma, Hepatocellular,
pubmed-meshheading:8380296-Chemotherapy, Adjuvant,
pubmed-meshheading:8380296-Child,
pubmed-meshheading:8380296-Child, Preschool,
pubmed-meshheading:8380296-Cisplatin,
pubmed-meshheading:8380296-Female,
pubmed-meshheading:8380296-Fluorouracil,
pubmed-meshheading:8380296-Humans,
pubmed-meshheading:8380296-Infant,
pubmed-meshheading:8380296-Liver Neoplasms,
pubmed-meshheading:8380296-Male,
pubmed-meshheading:8380296-Survival Analysis,
pubmed-meshheading:8380296-Vincristine
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study.
|
|
pubmed:affiliation |
Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, TN.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|
